National Cancer Institute funds early phase clinical trials for cancer treatment and diagnosis, focusing on targeted interventions relevant to specific research programs.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
Grant supports partnerships between academia and industry to translate scientific discoveries into tools for disease research and care worldwide.
Funding opportunity for academic-industrial partnerships to translate technologies for diagnosis and treatment in cancer research and care.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.